$3.59
$3.38
$20.25
$2.96
$183.2M
-53.13%
This is a preview of the full version of Prosperse
Hagens Berman is investigating Cardlytics, Inc. (CDLX) over allegations that the company may have misled investors about the prospects of its growth initiatives. The investigation follows Cardlytics' Q2 2024 financial results, which fell short of previous projections, leading to a 57% drop in the co...
N/A
Sep 16, 2024
Bragar Eagel & Squire, P.C. is investigating potential securities law violations by Arhaus, Cardlytics, and CVRx. The investigations focus on issues related to financial reporting, CEO departures, and reimbursement changes.
N/A
Aug 27, 2024
Hagens Berman, a shareholder rights firm, is investigating Cardlytics, Inc. (NASDAQ: CDLX) over allegations that the company may have misled investors about the prospects of its growth initiatives. The investigation follows Cardlytics' Q2 2024 financial results, which fell short of previous projecti...
N/A
Aug 19, 2024
Hagens Berman, a shareholder rights firm, is investigating Cardlytics, Inc. (NASDAQ: CDLX) over allegations that the company may have misled investors about the prospects of its growth initiatives. The investigation follows Cardlytics' Q2 2024 financial results, which fell short of previous projecti...
N/A
Aug 13, 2024
Date: Nov 19, 2024
Date: Nov 19, 2024
Date: Nov 14, 2024
Date: Nov 14, 2024
Date: Nov 14, 2024